Your browser doesn't support javascript.
loading
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
Pinato, David J; Tabernero, Josep; Bower, Mark; Scotti, Lorenza; Patel, Meera; Colomba, Emeline; Dolly, Saoirse; Loizidou, Angela; Chester, John; Mukherjee, Uma; Zambelli, Alberto; Dalla Pria, Alessia; Aguilar-Company, Juan; Ottaviani, Diego; Chowdhury, Amani; Merry, Eve; Salazar, Ramon; Bertuzzi, Alexia; Brunet, Joan; Lambertini, Matteo; Tagliamento, Marco; Pous, Anna; Sita-Lumsden, Ailsa; Srikandarajah, Krishnie; Colomba, Johann; Pommeret, Fanny; Seguí, Elia; Generali, Daniele; Grisanti, Salvatore; Pedrazzoli, Paolo; Rizzo, Gianpiero; Libertini, Michela; Moss, Charlotte; Evans, Joanne S; Russell, Beth; Harbeck, Nadia; Vincenzi, Bruno; Biello, Federica; Bertulli, Rossella; Liñan, Raquel; Rossi, Sabrina; Carmona-García, Maria Carmen; Tondini, Carlo; Fox, Laura; Baggi, Alice; Fotia, Vittoria; Parisi, Alessandro; Porzio, Giampero; Saponara, Maristella; Cruz, Claudia Andrea.
Afiliação
  • Pinato DJ; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy. Electronic address: david.pinato@imperial.ac.uk.
  • Tabernero J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain.
  • Bower M; Department of Oncology, Chelsea and Westminster Hospital, London, UK; National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK.
  • Scotti L; Unit of Medical Statistics, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
  • Patel M; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK.
  • Colomba E; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France.
  • Dolly S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Loizidou A; Department of Infectious Diseases, Internal Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Chester J; Medical Oncology, School of Medicine, Cardiff University, Cardiff, UK; Medical Oncology, Velindre Cancer Centre, Cardiff, UK.
  • Mukherjee U; Medical Oncology, Barts Health NHS Trust, London, UK.
  • Zambelli A; Oncology Unit, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
  • Dalla Pria A; Department of Oncology, Chelsea and Westminster Hospital, London, UK; National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK.
  • Aguilar-Company J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain.
  • Ottaviani D; Cancer Division, University College London Hospitals, London, UK.
  • Chowdhury A; Cancer Division, University College London Hospitals, London, UK.
  • Merry E; Cancer Division, University College London Hospitals, London, UK.
  • Salazar R; Department of Medical Oncology, ICO L'Hospitalet, Oncobell Program, Hospitalet de Llobregat, Barcelona, Spain.
  • Bertuzzi A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Brunet J; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain.
  • Lambertini M; Medical Oncology Department, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genova, Genova, Italy.
  • Tagliamento M; Medical Oncology Department, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genova, Genova, Italy.
  • Pous A; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain.
  • Sita-Lumsden A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Srikandarajah K; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Colomba J; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France.
  • Pommeret F; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France.
  • Seguí E; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.
  • Generali D; Multidisciplinary Breast Pathology and Translational Research Unit, Azienda Socio Sanitaria Territoriale Cremona, Cremona, Italy; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
  • Grisanti S; Medical Oncology Unit, Spedali Civili, Brescia, Italy; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Pedrazzoli P; Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy.
  • Rizzo G; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Libertini M; Medical Oncology Unit, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
  • Moss C; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Evans JS; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK.
  • Russell B; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Harbeck N; Department of Gynecology and Obstetrics, Breast Center and Gynecological Cancer Center and Comprehensive Cancer Center Munich, University Hospital Munich, Munich, Germany.
  • Vincenzi B; Policlinico Universitario Campus Bio-Medico, Rome, Italy.
  • Biello F; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Azienda Ospedaliera Maggiore Della Caritá, Novara, Italy.
  • Bertulli R; Medical Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Liñan R; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain.
  • Rossi S; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Carmona-García MC; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain.
  • Tondini C; Oncology Unit, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
  • Fox L; Haematology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain.
  • Baggi A; Medical Oncology Unit, Spedali Civili, Brescia, Italy; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Fotia V; Oncology Unit, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
  • Parisi A; Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
  • Porzio G; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Saponara M; Melanoma and Sarcoma Medical Treatment Unit, Istituto Europeo di Oncologia, Milan, Italy.
  • Cruz CA; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.
Lancet Oncol ; 22(12): 1669-1680, 2021 12.
Article em En | MEDLINE | ID: mdl-34741822
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article